Publications by authors named "Moshe Laudon"

Claim this Profile
C
Chronic Piromelatine Treatment Alleviates Anxiety, Depressive Responses and Abnormal Hypothalamic-Pituitary-Adrenal Axis Activity in Prenatally Stressed Male and Female Rats.
Natasha Ivanova, Zlatina Nenchovska, Milena Atanasova, Moshe Laudon, Rumyana Mitreva

Cell Mol Neurobiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
Elhanan Pinner, Yaron Gruper, Micha Ben Zimra, Don Kristt, Moshe Laudon

J Alzheimers Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet.
Jun Zhou, Deng Wang, XiaoHong Luo, Xu Jia, MaoXing Li, Moshe Laudon

J Pharmacol Exp Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats.
Jun Zhou, Jin Zhang, XiaoHong Luo, MaoXing Li, Ying Yue, Moshe Laudon

Eur J Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.
Paula Mosińska, Katarzyna Socała, Dorota Nieoczym, Moshe Laudon, Martin Storr

Behav Brain Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.
Wan Fu, Heng Xie, Moshe Laudon, Shouhong Zhou, Shaowen Tian

Psychopharmacology (Berl)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
Marta Zielińska, Agata Jarmuż, Maciej Sałaga, Radzisław Kordek, Moshe Laudon

Naunyn Schmiedebergs Arch Pharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance.
Xiuping Li, Shichang Cai, Weidong Yin, Xiaobo Hu, Sujun Zhang, Moshe Laudon

Acta Biochim Biophys Sin (Shanghai)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models.
Izaskun Buendia, Vanessa Gómez-Rangel, Laura González-Lafuente, Esther Parada, Rafael León, Moshe Laudon

Neuropharmacology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Alan G Wade, Mildred Farmer, Gil Harari, Naama Fund, Moshe Laudon

Clin Interv Aging· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin receptors in diabetes: a potential new therapeutical target?
Meihua She, Moshe Laudon, Weidong Yin

Eur J Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain.
Yuan-Yuan Liu, Dou Yin, Li Chen, Wei-Min Qu, Chang-Rui Chen, Moshe Laudon

Psychopharmacology (Berl)· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
Moshe Laudon, Anat Frydman-Marom

Int J Mol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307.
Meihua She, Hongjie Hou, Zongbao Wang, Chi Zhang, Moshe Laudon

Biochimie· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.
Meihua She, Xiaobo Hu, Zehong Su, Chi Zhang, Shenghua Yang, Moshe Laudon

Eur J Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.
Chunqiu Chen, Jakub Fichna, Moshe Laudon, Martin Storr

World J Gastroenterol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL.
Ping-Ping Wang, Mei-Hua She, Ping-Ping He, Wu-Jun Chen, Moshe Laudon

Biochimie· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation.
Thomas H Thatcher, Hsi-Min Hsiao, Elhanan Pinner, Moshe Laudon, Stephen J Pollock

Am J Physiol Lung Cell Mol Physiol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.
Pingping He, Xinping Ouyang, Shouhong Zhou, Weidong Yin, Chaoke Tang, Moshe Laudon

Horm Behav· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular effects of melatonin receptor agonists.
Ludovit Paulis, Fedor Simko, Moshe Laudon

Expert Opin Investig Drugs· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.
Ehud Grossman, Moshe Laudon, Nava Zisapel

Vasc Health Risk Manag· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
Patrick Lemoine, Doron Garfinkel, Moshe Laudon, Tali Nir, Nava Zisapel

Ther Clin Risk Manag· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
Doron Garfinkel, Mariana Zorin, Julio Wainstein, Zipora Matas, Moshe Laudon

Diabetes Metab Syndr Obes· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged-release melatonin for children with neurodevelopmental disorders.
Hélène De Leersnyder, Nava Zisapel, Moshe Laudon

Pediatr Neurol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Alan G Wade, Gordon Crawford, Ian Ford, Alex McConnachie, Tali Nir, Moshe Laudon

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis